Cargando…

CHIP protects against MPP(+)/MPTP-induced damage by regulating Drp1 in two models of Parkinson’s disease

Mitochondrial dysfunction has been implicated in the pathogenesis of Parkinson’s disease (PD). Carboxyl terminus of Hsp70-interacting protein (CHIP) is a key regulator of mitochondrial dynamics, and mutations in CHIP or deficits in its expression have been associated with various neurological diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zhengwei, Mao, Chengyuan, Wang, Hui, Zhang, Zhongxian, Zhang, Shuo, Luo, Haiyang, Tang, Mibo, Yang, Jing, Yuan, Yanpeng, Wang, Yanlin, Liu, Yutao, Fan, Liyuan, Zhang, Qimeng, Yao, Dabao, Liu, Fen, Schisler, Jonathan C., Shi, Changhe, Xu, Yuming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834979/ https://www.ncbi.nlm.nih.gov/pubmed/33472166 http://dx.doi.org/10.18632/aging.202389

Ejemplares similares

CHIP ameliorates cerebral ischemia-reperfusion injury by attenuating necroptosis and inflammation
por: Yao, Dabao, et al.
Publicado: (2021)

Analysis of 12 GWAS-Linked Loci With Parkinson’s Disease in the Chinese Han Population
por: Fan, Liyuan, et al.
Publicado: (2021)

Rapamycin reverses ferroptosis by increasing autophagy in MPTP/MPP(+)-induced models of Parkinson’s disease
por: Liu, Tongyu, et al.
Publicado: (2023)

Quercetin Protects against MPP(+)/MPTP-Induced Dopaminergic Neuron Death in Parkinson's Disease by Inhibiting Ferroptosis
por: Lin, Zhi-Hao, et al.
Publicado: (2022)

Changes of MAO-A and MAO-B Expressions in the Placenta of MPTP or MPP(+) Treated Mice
por: Sai, Takafumi, et al.
Publicado: (2013)

CHCHD2 p.Thr61Ile knock‐in mice exhibit motor defects and neuropathological features of Parkinson's disease
por: Fan, Liyuan, et al.
Publicado: (2022)

Echinacoside protects against MPTP/MPP(+)-induced neurotoxicity via regulating autophagy pathway mediated by Sirt1
por: Chen, Chang, et al.
Publicado: (2018)

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons
por: Aguirre, Pabla, et al.
Publicado: (2015)

Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells
por: Hu, Xinchao, et al.
Publicado: (2020)

Deciphering Neurodegenerative Diseases Using Long-Read Sequencing
por: Su, Yun, et al.
Publicado: (2021)

The Association of Iron and the Pathologies of Parkinson’s Diseases in MPTP/MPP(+)-Induced Neuronal Degeneration in Non-human Primates and in Cell Culture
por: Shi, Liangqin, et al.
Publicado: (2019)

Neuroprotective Effects of San-Huang-Xie-Xin-Tang in the MPP(+)/MPTP Models of Parkinson's Disease In Vitro and In Vivo
por: Lo, Yi-Ching, et al.
Publicado: (2012)

Neuroprotective and Neurorestorative Effects of Holothuria scabra Extract in the MPTP/MPP(+)-Induced Mouse and Cellular Models of Parkinson’s Disease
por: Noonong, Kunwadee, et al.
Publicado: (2020)

Calcitriol Alleviates MPP(+)- and MPTP-Induced Parthanatos Through the VDR/PARP1 Pathway in the Model of Parkinson’s Disease
por: Hu, Junjie, et al.
Publicado: (2021)

Botanical Drug Puerarin Promotes Neuronal Survival and Neurite Outgrowth against MPTP/MPP(+)-Induced Toxicity via Progesterone Receptor Signaling
por: Zhao, Yingke, et al.
Publicado: (2020)

Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP(+)-Treated Neurons
por: Petit-Paitel, Agnès, et al.
Publicado: (2009)

Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP(+) and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling Pathway
por: Guo, Xingfang, et al.
Publicado: (2019)

Magnolol Protects against MPTP/MPP(+)-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson's Disease
por: Muroyama, Akiko, et al.
Publicado: (2012)

New Insights Into the Pathogenesis of Alzheimer's Disease
por: Fan, Liyuan, et al.
Publicado: (2020)

The Alteration of Nasopharyngeal and Oropharyngeal Microbiota in Children with MPP and Non-MPP
por: Lu, Zhiwei, et al.
Publicado: (2017)

The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1
por: Perez Carrion, Maria, et al.
Publicado: (2018)

Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson’s disease model induced by MPTP
por: Filichia, Emily, et al.
Publicado: (2016)

Long non-coding RNA NEAT1 mediates MPTP/MPP(+)-induced apoptosis via regulating the miR-124/KLF4 axis in Parkinson’s disease
por: Liu, Jiyao, et al.
Publicado: (2020)

Mitochondrial Drp1 recognizes and induces excessive mPTP opening after hypoxia through BAX-PiC and LRRK2-HK2
por: Duan, Chenyang, et al.
Publicado: (2021)

Plasma Homocysteine, Vitamin B12 and Folate Levels in Multiple System Atrophy: A Case-Control Study
por: Zhang, Shuyu, et al.
Publicado: (2015)

Rare KCND3 Loss-of-Function Mutation Associated With the SCA19/22
por: Li, Mengjie, et al.
Publicado: (2022)

Suppressing Cdk5 Activity by Luteolin Inhibits MPP(+)-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β Pathways
por: Reudhabibadh, Ratchaneekorn, et al.
Publicado: (2021)

Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants
por: Yang, Jing, et al.
Publicado: (2021)

2013 MPP Workshop
por: Jonker, Michael
Publicado: (2014)

Nesfatin-1 protects dopaminergic neurons against MPP(+)/MPTP-induced neurotoxicity through the C-Raf–ERK1/2-dependent anti-apoptotic pathway
por: Shen, Xiao-Li, et al.
Publicado: (2017)

Abnormal Mitochondria in a Non-human Primate Model of MPTP-induced Parkinson's Disease: Drp1 and CDK5/p25 Signaling
por: Park, Junghyung, et al.
Publicado: (2019)

Characteristics of the mitochondrial and cellular uptake of MPP(+), as probed by the fluorescent mimic, 4'I-MPP(+)
por: Mapa, Mapa S. T., et al.
Publicado: (2018)

Proceedings of the 2019 MPP Workshop
por: Strachinescu, Sabina-Ioana, et al.
Publicado: (2019)

Meningeal immunity and neurological diseases: new approaches, new insights
por: Su, Yun, et al.
Publicado: (2023)

The MPTP Story
por: Langston, J. William
Publicado: (2017)

Genetic spectrum and clinical features of adult leukoencephalopathies in a Chinese cohort
por: Liu, Minglei, et al.
Publicado: (2023)

Neuroprotective Effects of Gagam-Sipjeondaebo-Tang, a Novel Herbal Formula, against MPTP-Induced Parkinsonian Mice and MPP(+)-Induced Cell Death in SH-SY5Y Cells
por: Ko, Jade Heejae, et al.
Publicado: (2018)

Increased PRR14 and VCAM-1 level in serum of patients with Parkinson's disease
por: Zheng, Huimin, et al.
Publicado: (2022)

Clinical application of prion-like seeding in α-synucleinopathies: Early and non-invasive diagnosis and therapeutic development
por: Li, Jiaqi, et al.
Publicado: (2022)

MIEF1/2 function as adaptors to recruit Drp1 to mitochondria and regulate the association of Drp1 with Mff
por: Yu, Rong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ru0314qlaq4ac81r5ts0ftnsp8